FEATURED

Pembrolizumab for Advanced Melanoma

This PD-1 inhibitor is effective for treating melanoma, though it can be highly toxic and there is a lack of biomarkers for predicting a response.

Bayesian Adaptive Randomization for Clinical Trials

Researchers developed a novel Bayesian adaptive randomization method that maximizes efficiency by focusing the algorithm to reduce uncertainty within patient-treatment baskets.

In Focus: Atezolizumab for NSCLC

Atezolizumab is the most recent in a line of immune checkpoint inhibitors approved for patients with NSCLC.

Q&A With Tanya Wildes, MD

In this question-and-answer session, Cancer Therapy Advisor asked Dr Wildes about the management of multiple myeloma among older patients.

Nutritional Challenges in Post–Whipple Surgery

Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.

Fact Sheet: Smoking Cessation and Cancer

NCCN guidelines recommend that smoking cessation be provided as part of oncology treatment.

Atypical CML: Current Research, Treatment Strategies

Strategies that work for patients with CML fail for aCML cases, though some new research is promising.

Drug Showcase: IMLYGIC (talimogene laherparepvec)

Indicated for melanoma.

Role of Diet in Breast Cancer

More prospective studies are needed to determine the role of diet and the underlying mechanisms that explain dietary benefits among women with breast cancer.

In ER+, early-stage breast cancer

Individualizing treatment with extended adjuvant endocrine therapy

For the treatment of metastatic non-small

Biomarker testing for epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations is important when considering a first-line therapy

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

In ER+, early-stage breast cancer

Experts discuss risk vs benefit of extended adjuvant endocrine therapy

Featured Resource

A multidisciplinary team (MDT) approach is necessary in treating metastatic breast cancer in order to provide optimal care. This article, published in JNCCN, reviews the findings of an educational needs assessment of the multidisciplinary breast cancer management team.


Latest Features

Pembrolizumab for Advanced Melanoma: Efficacy and Toxicity

Pembrolizumab for Advanced Melanoma: Efficacy and Toxicity

This PD-1 inhibitor is effective for treating melanoma, though it can be highly toxic and there is a lack of biomarkers for predicting a response.

Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD

Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD

Researchers developed a novel Bayesian adaptive randomization method that maximizes efficiency by focusing the algorithm to reduce uncertainty within patient-treatment baskets.

In Focus: Atezolizumab for Non-small Cell Lung Cancer

In Focus: Atezolizumab for Non-small Cell Lung Cancer

Atezolizumab is the most recent in a line of immune checkpoint inhibitors approved for patients with NSCLC.

Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients

Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients

In this question-and-answer session, Cancer Therapy Advisor asked Dr Wildes about the management of multiple myeloma among older patients.

Nutritional Challenges in Patients Post-Whipple Surgery

Nutritional Challenges in Patients Post-Whipple Surgery

Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters